ImmuCell
ICCC
28 hedge funds and large institutions have $5.74M invested in ImmuCell in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 4 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
1.19% more ownership
Funds ownership: 13.35% → 14.54% (+1.2%)
5% more capital invested
Capital invested by funds: $5.47M → $5.74M (+$269K)
7% less funds holding
Funds holding: 30 → 28 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$397K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$96.5K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$78.9K |
| 4 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
+$59.4K |
| 5 |
Renaissance Technologies
New York
|
+$23.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$144K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$77.5K |
| 3 |
HL
HeadInvest LLC
Portland,
Maine
|
-$16.3K |
| 4 |
BlackRock
New York
|
-$4.48K |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
-$3.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$883 | +181 | +670% |
|
27
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $774 | – | – | – |
|
28
JP Morgan Chase
New York
| $45 | +$10 | +2 | +29% |
|
|
PCM
29
Perritt Capital Management
Chicago,
Illinois
| – | -$144K | -27,026 | Closed |
|
|
30
Citadel Advisors
Miami,
Florida
| – | -$77.5K | -15,019 | Closed |
|
|
HL
31
HeadInvest LLC
Portland,
Maine
| – | -$16.3K | -3,118 | Closed |
|
|
32
US Bancorp
Minneapolis,
Minnesota
| – | -$3.2K | -600 | Closed |
|
ICCC Hedge Fund Activity: Q4 2023 in Review
28 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2023, worth a combined $5.74M — up 4.9% from $5.47M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ICCC and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 10 added.
The largest buyer was Morgan Stanley, adding an estimated $397K. The largest seller was Perritt Capital Management, exiting entirely with an estimated $144K sold.
- 28 institutional investors held ImmuCell (ICCC) as of Q4 2023, down from 30 in Q3 2023.
- Funds reported $5.74M of ImmuCell stock for Q4 2023, up 4.9% quarter-over-quarter.
- 2 funds opened new ImmuCell positions in Q4 2023 and 4 closed out, a net change of -2 holders.
- The largest ImmuCell buyer in Q4 2023 was Morgan Stanley, an estimated $397K added.
- The largest ImmuCell seller in Q4 2023 was Perritt Capital Management, an estimated $144K sold.
Based on aggregated 13F filings for Q4 2023.